View Single Post
Old 03-17-2018, 03:38 AM
johnt johnt is offline
Senior Member
 
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
15 yr Member
johnt johnt is offline
Senior Member
 
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
15 yr Member
Default Critique of Parkinson's research organization

Ben Stecher et al. [1] critique the way research into Parkinson's is organized.

"the pace of novel advances seems to be slowed down by a system that can not move fast enough to keep up with our own neurodegeneration."

"This clinical trial model ... seems ill-equipped to tackle PD where etiological heterogeneity is the rule rather than the exception."

Reference:

[1 ]Ben Stecher et al.
thebmjopinion, 13 Mar 2018
Ben Stecher et al: Research into Parkinson’s Disease needs reform – The BMJ

John
__________________
Born 1955. Diagnosed PD 2005.
Meds 2010-Nov 2016: Stalevo(75 mg) x 4, ropinirole xl 16 mg, rasagiline 1 mg
Current meds: Stalevo(75 mg) x 5, ropinirole xl 8 mg, rasagiline 1 mg
johnt is offline   Reply With QuoteReply With Quote